Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday

Cytek Biosciences (NASDAQ:CTKB - Get Free Report) is scheduled to be announcing its earnings results after the market closes on Tuesday, November 5th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. Cytek Biosciences has set its FY 2024 guidance at EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.

Cytek Biosciences (NASDAQ:CTKB - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.05). Cytek Biosciences had a negative net margin of 8.88% and a negative return on equity of 3.75%. The company had revenue of $46.62 million for the quarter, compared to the consensus estimate of $49.02 million. During the same period last year, the company posted ($0.02) earnings per share. On average, analysts expect Cytek Biosciences to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cytek Biosciences Price Performance

CTKB stock traded up $0.09 on Wednesday, reaching $4.90. The company's stock had a trading volume of 352,849 shares, compared to its average volume of 669,729. The firm has a fifty day moving average of $5.23 and a two-hundred day moving average of $5.67. The company has a market capitalization of $644.38 million, a P/E ratio of -35.00 and a beta of 1.30. Cytek Biosciences has a 52 week low of $3.80 and a 52 week high of $9.87.

Wall Street Analysts Forecast Growth

Separately, Piper Sandler lowered their target price on shares of Cytek Biosciences from $8.50 to $8.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 13th.

Cytek Biosciences Company Profile

Cytek Biosciences, Inc, a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems.